Sfoglia per AUTORE
IELMINI N
Collezione ASL Biella

  

Items : 3

IELSG38: phase II trial of front-line chlorambucil plus subcutaneous rituximab induction and maintenance in mucosa-associated lymphoid tissue lymphoma. in Haematologica / Haematologica. 2024 Aug 1;109(8):2564-2573. doi: 10.3324/haematol.2023.283918.

2024
ASL Biella
AOU Alessandria
AOU Città della Salute di Torino

Thieblemont C; Zucca E; Luminari S; Bertoni F; Rossi D; Cavalli F; Pietrantuono G; Re F; Spina M; Landi F; Houot R; Merli M; Liberati AM; Haioun C; Cartron G; Devizzi L; Occhini U; Casasnovas RO; Califano C; Celli M; Pulsoni A; Angrilli F; Conconi A; Tessoulin B; Tilly H; Zanni M; Cabras MG; Capochiani E; Morschhauser F; et alii...

Impact of different induction regimens on the outcome of primary mediastinal b cell lymphoma in the prospective IELSG 37 trial in Hematological Oncology

2021
ASL Biella
AOU Città della Salute di Torino
AOU Alessandria

Kryachok I; Ceriani L; Balzarotti M; Tucci A; Cabras MG; Zilioli VR; Rusconi C; Angrilli F; Arcaini L; Dabrowska Iwanicka A; Ferreri AJM; Merli F; Zhao W; Hodgson D; Ionescu C; Fosså A; Cwynarski K; Mikhaeel G; Jerkeman M; Janikova A; Hüttmann A; Ciccone G; Metser U; Barrington S; Malkowski B; Versari A; Esposito F; Cozens K; Ielmini N; et alii...

IELSG-38: A phase II study of chlorambucil in combination with rituximab followed by maintenance therapy with subcutaneous rituximab in patients with extranodal marginal zone B-cell lymphoma of mucosa associated lymphoid tissue (MALT) in Blood

2017
ASL Biella

Luminari S; Cavalli F; Zucca E; Thieblemont C; Molinari AL; Pulsoni A; Ielmini N; Cabras MG; Capochiani E; Califano C; Tilly H; Salvi F; Conconi A; Palombi F; Cavallo F; Gouill SL; Gini G; Ferrari A; Gyan E; Morschhauser F; Coiffier B; Musuraca G; Guieze R; Marino D; Stathis A; Gregorini A; Gressin R; Orsucci L; Perrot A; et alii...